{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:49:11Z","timestamp":1780516151729,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":6423,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1017\/s1041610207005261","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T13:16:04Z","timestamp":1178284564000},"page":"421-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Global measures: utility in defining and measuring treatment response in dementia"],"prefix":"10.1016","volume":"19","author":[{"given":"Barry","family":"Reisberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610207005261_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1017\/S1041610207005261_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1017\/S1041610207005261_bb0015","doi-asserted-by":"crossref","unstructured":"Auer, S. R., Monteiro, I. M. and Reisberg, B. (1996). The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale. International Psychogeriatrics, 8, 247-266. Berg, L. (1988). Clinical dementia rating (CDR). Psychopharmacology Bulletin, 24, 637-639. Bobinski, M. et al. (1995). Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia, 6, 205-210.","DOI":"10.1017\/S1041610296002621"},{"key":"10.1017\/S1041610207005261_bb0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00005072-199704000-00010","article-title":"Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease","volume":"56","author":"Bobinski","year":"1997","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1017\/S1041610207005261_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-2006-9S305","article-title":"Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases","volume":"9","author":"Braak","year":"2006","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1017\/S1041610207005261_bb0030","first-page":"55","article-title":"A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartarate), a new acetylcholinesterase inhibitor, in patients with Mild to Moderately severe Alzheimer's disease","volume":"1","author":"Corey-Bloom, J., Anand, R. and Veach, J., for the ENA 713 B352 Study Group","year":"1998","journal-title":"International Journal of Geriatric Psychopharmacology"},{"issue":"Suppl. 2","key":"10.1017\/S1041610207005261_bb0035","first-page":"S1","article-title":"A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results","volume":"11","author":"Ferris","year":"1997","journal-title":"The Alzheimer's Disease Cooperative Study. Alzheimer's Disease and Associated Disorders"},{"key":"10.1017\/S1041610207005261_bb0040","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.41.7.1006","article-title":"Mild cognitive impairment in the elderly: predictors of dementia","volume":"41","author":"Flicker","year":"1991","journal-title":"Neurology"},{"key":"10.1017\/S1041610207005261_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S1041610207005261_bb0050","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1093\/geronj\/48.6.S310","article-title":"Principal lifetime occupation and MMSE score in elderly persons","volume":"48","author":"Frisoni","year":"1993","journal-title":"Journal of Gerontology"},{"issue":"Suppl. 2","key":"10.1017\/S1041610207005261_bb0055","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer's Disease and Associated Disorders"},{"key":"10.1017\/S1041610207005261_bb0060","first-page":"1262","article-title":"Detailed assessment of cognition and activities of daily living in Moderate to Severe Alzheimer's disease. Neurobiology of Aging, 21 (Suppl. 1), S168. Gauthier, S. et al. (2006). Mild Cognitive Impairment","volume":"367","author":"Galasko","year":"2000","journal-title":"Lancet"},{"key":"10.1017\/S1041610207005261_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/ajp.156.4.531","article-title":"Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition","volume":"156","author":"Geerlings","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610207005261_bb0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.31887\/DCNS.2004.6.4\/jgolomb","article-title":"Mild cognitive impairment: historical development and summary of research","volume":"6","author":"Golomb","year":"2004","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1017\/S1041610207005261_bb0075","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"218","article-title":"Clinical Global Impression (CGI)","author":"Guy","year":"1976"},{"key":"10.1017\/S1041610207005261_bb0080","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1532-5415.1994.tb06984.x","article-title":"The MDS Cognition Scale: a valid instrument for identifying and staging nursing home residents with dementia using the minimum data set","volume":"42","author":"Hartmaier","year":"1994","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610207005261_bb0085","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"Anew clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610207005261_bb0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S0033291701003245","article-title":"Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7-8 years","volume":"31","author":"Jorm","year":"2001","journal-title":"Psychological Medicine"},{"key":"10.1017\/S1041610207005261_bb0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/089198879901200402","article-title":"Neuropsychological prediction of decline to dementia in nondemented elderly","volume":"12","author":"Kluger","year":"1999","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1017\/S1041610207005261_bb0100","series-title":"Unpublished letter to pharmaceutical companies [Issues affecting the implementation of the Clinician's Global Assessment]","author":"Leber","year":"1991"},{"key":"10.1017\/S1041610207005261_bb0105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1017\/S1041610207005261_bb0110","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1017\/S1041610207005261_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/089198879600900404","article-title":"Clinical evaluation of global change in Alzheimer's disease: Identifying consensus","volume":"9","author":"Olin","year":"1996","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1017\/S1041610207005261_bb0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/089198879000300407","article-title":"Empirical scaling of the stages of cognitive decline in senile dementia","volume":"3","author":"Overall","year":"1990","journal-title":"Journal of Geriatric Psychiatry andNeurology"},{"key":"10.1017\/S1041610207005261_bb0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"Journal of Internal Medicine"},{"key":"10.1017\/S1041610207005261_bb0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610207005261_bb0135","doi-asserted-by":"crossref","unstructured":"Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., and DeKosky, S. T. (2001). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1133-1142.","DOI":"10.1212\/WNL.56.9.1133"},{"key":"10.1017\/S1041610207005261_bb0140","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"New England Journal Medicine"},{"key":"10.1017\/S1041610207005261_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0197-4580(94)90147-3","article-title":"Quantitative EEG correlates of cognitive deterioration in the elderly","volume":"15","author":"Prichep","year":"1994","journal-title":"Neurobiology of Aging"},{"key":"10.1017\/S1041610207005261_bb0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neurobiolaging.2005.07.021","article-title":"Prediction of longitudinal cognitive decline in normal elderly using electrophysiological imaging","volume":"27","author":"Prichep","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1017\/S1041610207005261_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1532-5415.2005.00589.x","article-title":"Memory complaint is not necessary for diagnosis of mild cognitive impairment and does not predict 10-year trajectories of functional disability, word recall, or short portable mental status questionnaire limitations","volume":"54","author":"Purser","year":"2006","journal-title":"Journal of the American Geriatrics Society"},{"issue":"4","key":"10.1017\/S1041610207005261_bb0160","first-page":"30","article-title":"Dementia: a systematic approach to identifying reversible causes","volume":"41","author":"Reisberg","year":"1986","journal-title":"Geriatrics"},{"key":"10.1017\/S1041610207005261_bb0165","first-page":"653","article-title":"Functional assessment staging (FAST)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1017\/S1041610207005261_bb0170","first-page":"629","article-title":"The Brief Cognitive Rating Scale (BCRS)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1017\/S1041610207005261_bb0175","series-title":"Guide to Assessment Scales in Dementia","article-title":"Clinician's Interview-Based Impression of Change-Plus","author":"Reisberg","year":"2004"},{"key":"10.1017\/S1041610207005261_bb0180","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610207005261_bb0185","series-title":"Senile Dementia of the Alzheimer Type","first-page":"18","article-title":"Senile dementia of the Alzheimer type: diagnostic and differential diagnostic features with special reference to functional assessment staging","volume":"2","author":"Reisberg","year":"1985"},{"key":"10.1017\/S1041610207005261_bb0190","series-title":"Geriatric Psychiatry: Ethical and Legal Issues","first-page":"37","article-title":"Insight and denial accompanying progressive cognitive decline in normal aging and Alzheimer's disease","author":"Reisberg","year":"1985"},{"issue":"5, Suppl","key":"10.1017\/S1041610207005261_bb0195","first-page":"9","article-title":"Behavioral symptoms in Alzheimer's disease: phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610207005261_bb0200","first-page":"661","article-title":"The Global Deterioration Scale (GDS)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1017\/S1041610207005261_bb0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ddr.430150203","article-title":"Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment and primary degenerative dementia of the Alzheimer type","volume":"15","author":"Reisberg","year":"1988","journal-title":"Drug Development Research"},{"key":"10.1017\/S1041610207005261_bb0210","series-title":"Special Research Methods for Gerontology","first-page":"195","article-title":"Longitudinal study of dementia patients and aged controls: an approach to methodologic issues","author":"Reisberg","year":"1989"},{"key":"10.1017\/S1041610207005261_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S1041610292001133","article-title":"Pharmacologic treatment of Alzheimer's disease: a methodologic critique based upon current knowledge of symptomatology and relevance for drug trials","volume":"4","author":"Reisberg","year":"1992","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610207005261_bb0220","first-page":"551","article-title":"Clinical stages of normal aging and Alzheimer's disease: the GDS staging system","volume":"13","author":"Reisberg","year":"1993","journal-title":"Neuroscience Research Communications"},{"key":"10.1017\/S1041610207005261_bb0225","first-page":"S188","article-title":"Dementia staging in chronic care populations","volume":"8","author":"Reisberg","year":"1994","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1017\/S1041610207005261_bb0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S1041610296002657","article-title":"Mortality and temporal course of probable Alzheimer's disease: a five-year prospective study","volume":"8","author":"Reisberg","year":"1996","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610207005261_bb0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S1041610296002566","article-title":"Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer's disease","volume":"8","author":"Reisberg","year":"1996","journal-title":"International Psychogeriatrics"},{"issue":"Suppl. 3","key":"10.1017\/S1041610207005261_bb0240","first-page":"8","article-title":"Clinical global measures of dementia: position paper from the International Working Group on Harmonization of Dementia Drug Guidelines","volume":"11","author":"Reisberg","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1017\/S1041610207005261_bb0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1041610201007566","article-title":"The Alzheimer's disease Activities of Daily Living International Scale (ADL-IS)","volume":"13","author":"Reisberg","year":"2001","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610207005261_bb0250","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate- to- severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"Suppl. 1","key":"10.1017\/S1041610207005261_bb0255","first-page":"S81","article-title":"Subjective Cognitive Impairment: the pre-Mild Cognitive Impairment stage of brain degeneration: longitudinal outcome after a mean of 7 years follow-up","volume":"30","author":"Reisberg","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1017\/S1041610207005261_bb0260","series-title":"Severe Dementia","first-page":"83","article-title":"Clinical features of severe dementia: staging","author":"Reisberg","year":"2006"},{"key":"10.1017\/S1041610207005261_bb0265","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.158.9.1021","article-title":"Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study","volume":"158","author":"Rogers, S. L., Doody, R. S., Mohs, R. C., Friedhoff, L. T. and the Donepezil Study Group","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"10.1017\/S1041610207005261_bb0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease","volume":"50","author":"Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T. and the Donepezil Study Group","year":"1998","journal-title":"Neurology"},{"key":"10.1017\/S1041610207005261_bb0275","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610207005261_bb0280","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.318.7184.633","article-title":"Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomized controlled trial","volume":"318","author":"Rosier","year":"1999","journal-title":"BMJ"},{"key":"10.1017\/S1041610207005261_bb0285","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.wnl.0000234032.77541.a2","article-title":"Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI","volume":"67","author":"Saykin","year":"2006","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1017\/S1041610207005261_bb0290","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00002093-199700112-00008","article-title":"The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Schmitt","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1017\/S1041610207005261_bb0295","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability ofthe Alzheimer disease cooperative study-clinical global impression of change","volume":"1 1 (Suppl. 2)","author":"Schneider","year":"1997","journal-title":"Alzheimer's Disease and Associated Disorders"},{"key":"10.1017\/S1041610207005261_bb0300","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1097\/01.wad.0000213878.47924.44","article-title":"ADCS Prevention Instrument Project: ADCS-Clinicians Global Impression of Change Scales (ADCS-CGIC), self-rated and study partner-rated versions","volume":"3","author":"Schneider","year":"2006","journal-title":"Alzheimer's Disease and Associated Disorders"},{"issue":"Suppl.1","key":"10.1017\/S1041610207005261_bb0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1041610292001157","article-title":"Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity and ordinality","volume":"4","author":"Sclan","year":"1992","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610207005261_bb0310","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/(SICI)1099-1166(199609)11:9<819::AID-GPS389>3.0.CO;2-S","article-title":"The Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): reliability and analysis of symptom category scores","volume":"11","author":"Sclan","year":"1996","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610207005261_bb0315","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S. and Gergel, I. for the Memantine Study Group","year":"2004","journal-title":"JAMA"},{"key":"10.1017\/S1041610207005261_bb0320","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1017\/S0033291700035029","article-title":"The Gospel Oak Study stage IV: the clinical relevance of subjective memory impairment in older people","volume":"25","author":"Tobiansky","year":"1995","journal-title":"Psychological Medicine"},{"key":"10.1017\/S1041610207005261_bb0325","series-title":"Beoordelings schaal voor oudere patienten (BOP)","author":"VanDerKam","year":"1971"},{"key":"10.1017\/S1041610207005261_bb0330","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/j.1532-5415.2004.52568.x","article-title":"Subjective memory deterioration and future dementia in people aged 65 and older","volume":"52","author":"Wang","year":"2004","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610207005261_bb0335","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1532-5415.1995.tb07057.x","article-title":"Literacy and performance on the Mini-mental State Examination","volume":"43","author":"Weiss","year":"1995","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610207005261_bb0340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0","article-title":"Memantine in severe dementia: results of the 9M-Best Study (benefit and efficacy in severely demented patients during treatment with memantine)","volume":"14","author":"Winblad","year":"1999","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610207005261_bb0345","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"Journal of Internal Medicine"},{"key":"10.1017\/S1041610207005261_bb0350","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(06)68350-5","article-title":"Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study","volume":"367","author":"Winblad","year":"2006","journal-title":"Lancet"},{"key":"10.1017\/S1041610207005261_bb0355","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.neurobiolaging.2004.11.003","article-title":"Subjective memory complaints in aging are associated with elevated cortisol levels","volume":"26","author":"Wolf","year":"2005","journal-title":"Neurobiology of Aging"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224046775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224046775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610207005261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:24:29Z","timestamp":1736468669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224046775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1041610224046775"],"URL":"https:\/\/doi.org\/10.1017\/s1041610207005261","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global measures: utility in defining and measuring treatment response in dementia","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610207005261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}